underwriters

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private PlacementSenseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private Placement

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters Option to Purchase Additional Shares, and Closing of Private Placement

May 21, 2025 17:06 ET  | Source: Senseonics Holdings, Inc. Public offering results in gross proceeds of $57.5 millionPrivate placement…

13 hours ago
Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public OfferingKestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public Offering

Kestra Medical Technologies, Ltd. Announces Full Exercise and Closing of Underwriters’ Over-Allotment Option in Initial Public Offering

KIRKLAND, Wash., March 14, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare…

2 months ago
Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment OptionBrag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option

Brag House Holdings, Inc. Announces Full Exercise of Underwriters Over-Allotment Option

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Brag House Holdings, Inc. (Nasdaq: TBH) ("Brag House" or the "Company") today…

2 months ago
LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment OptionLZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option

LZ Technology Holdings Limited Announces Underwriters Full Exercise of Over-Allotment Option

HUZHOU CITY, China, March 11, 2025 (GLOBE NEWSWIRE) -- LZ Technology Holdings Limited (NASDAQ: LZMH) (“LZ Technology” or the “Company”),…

2 months ago
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common StockIntelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock

February 21, 2025 16:05 ET  | Source: Intelligent Bio Solutions, Inc. NEW YORK, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Intelligent…

3 months ago
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional SharesBeta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares

January 31, 2025 17:56 ET  | Source: Beta Bionics, Inc. IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics,…

4 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago
NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional SharesNewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters Option to Purchase Additional Shares

December 13, 2024 17:16 ET | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE)…

5 months ago